• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子增强甲状腺刺激素受体刺激自身抗体在格雷夫斯眼病患者眼眶成纤维细胞的反应。

PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.

机构信息

Department of Immunology, Erasmus Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

出版信息

J Clin Endocrinol Metab. 2012 Jun;97(6):E944-53. doi: 10.1210/jc.2012-1020. Epub 2012 Mar 21.

DOI:10.1210/jc.2012-1020
PMID:22438231
Abstract

PURPOSE

Thyroid-stimulating hormone receptor (TSHR) stimulating autoantibodies are associated with Graves' ophthalmopathy (GO), the orbital manifestation of Graves' disease (GD). TSHR autoantibody levels and orbital TSHR expression levels correlate positively with GO disease activity. Platelet-derived growth factors (PDGF) are increased in GO and potently activate orbital fibroblast effector functions. We investigated the possible relationship between PDGF and TSHR expression on orbital fibroblasts and how that influences the immunopathological effects of TSHR autoantibodies on orbital fibroblast activity.

METHODS

Orbital fibroblasts were stimulated with PDGF-AA, PDGF-AB, and PDGF-BB, and TSHR expression was determined by flow cytometry. Stimulatory effects of bovine TSH and GD immunoglobulins on orbital fibroblasts (with or without PDGF-BB preincubation) were determined by IL-6, IL-8, chemokine (C-C motif) ligand (CCL)-2, CCL5, CCL7, and hyaluronan ELISA. The TSHR blocking antibody K1-70 and the cAMP inhibitor H89 were used to determine involvement of TSHR signaling.

RESULTS

PDGF-AB and PDGF-BB stimulation increased TSHR expression on orbital fibroblasts, whereas PDGF-AA did not. Furthermore, stimulation with bovine TSH and immunoglobulins from GD patients induced IL-6, IL-8, CCL2, and hyaluronan production by orbital fibroblasts, and PDGF-BB preincubation enhanced this response of orbital fibroblasts. Blocking studies with a TSHR blocking antibody and a cAMP inhibitor inhibited these effects, indicating the involvement of TSHR signaling and thus of TSHR stimulating autoantibodies herein.

CONCLUSIONS

These findings indicate that PDGF-B containing PDGF isoforms amplify the immunopathological effects of TSHR-stimulating autoantibodies in GO patients by stimulating TSHR expression on orbital fibroblasts.

摘要

目的

促甲状腺激素受体(TSHR)刺激自身抗体与 Graves 眼病(GO)有关,GO 是 Graves 病(GD)的眼眶表现。TSHR 自身抗体水平和眼眶 TSHR 表达水平与 GO 疾病活动呈正相关。血小板衍生生长因子(PDGF)在 GO 中增加,并强烈激活眼眶成纤维细胞效应功能。我们研究了 PDGF 与眼眶成纤维细胞上的 TSHR 表达之间的可能关系,以及这如何影响 TSHR 自身抗体对眼眶成纤维细胞活性的免疫病理作用。

方法

用 PDGF-AA、PDGF-AB 和 PDGF-BB 刺激眼眶成纤维细胞,并用流式细胞术测定 TSHR 表达。通过 IL-6、IL-8、趋化因子(C-C 基序)配体(CCL)-2、CCL5、CCL7 和透明质酸 ELISA 测定牛 TSH 和 GD 免疫球蛋白对眼眶成纤维细胞的刺激作用(有无 PDGF-BB 预孵育)。使用 TSHR 阻断抗体 K1-70 和 cAMP 抑制剂 H89 来确定 TSHR 信号转导的参与。

结果

PDGF-AB 和 PDGF-BB 刺激增加了眼眶成纤维细胞上的 TSHR 表达,而 PDGF-AA 则没有。此外,牛 TSH 和 GD 患者的免疫球蛋白刺激诱导了眼眶成纤维细胞产生 IL-6、IL-8、CCL2 和透明质酸,而 PDGF-BB 预孵育增强了眼眶成纤维细胞的这种反应。TSHR 阻断抗体和 cAMP 抑制剂的阻断研究抑制了这些作用,表明 TSHR 信号转导的参与,因此也参与了本文中的 TSHR 刺激自身抗体。

结论

这些发现表明,含有 PDGF-B 的 PDGF 同工型通过刺激眼眶成纤维细胞上的 TSHR 表达,放大了 GO 患者 TSHR 刺激自身抗体的免疫病理作用。

相似文献

1
PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.血小板衍生生长因子增强甲状腺刺激素受体刺激自身抗体在格雷夫斯眼病患者眼眶成纤维细胞的反应。
J Clin Endocrinol Metab. 2012 Jun;97(6):E944-53. doi: 10.1210/jc.2012-1020. Epub 2012 Mar 21.
2
Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.促甲状腺素和促甲状腺素受体刺激 Graves 病免疫球蛋白 G 对 Graves 眼病患者未分化眼眶成纤维细胞中环腺苷酸单磷酸和透明质酸产生的影响。
Thyroid. 2010 May;20(5):535-44. doi: 10.1089/thy.2009.0447.
3
Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.促甲状腺素受体刺激性 Graves 眼病免疫球蛋白不仅通过环腺苷酸信号通路诱导 Graves 眼病患者分化的眼眶成纤维细胞合成透明质酸。
Thyroid. 2011 Feb;21(2):169-76. doi: 10.1089/thy.2010.0123. Epub 2010 Oct 18.
4
Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.血小板衍生生长因子-BB:格雷夫斯眼病眼眶成纤维细胞细胞因子产生的刺激物。
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1002-7. doi: 10.1167/iovs.09-4338. Epub 2009 Sep 24.
5
Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.眼眶成纤维细胞在格雷夫斯眼病发病机制中作用的当前观点
Exp Eye Res. 2016 Jan;142:83-91. doi: 10.1016/j.exer.2015.02.007.
6
A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.一种小分子拮抗剂抑制促甲状腺激素受体抗体诱导的眼眶成纤维细胞功能,该功能涉及格雷夫斯眼病的发病机制。
J Clin Endocrinol Metab. 2013 May;98(5):2153-9. doi: 10.1210/jc.2013-1149. Epub 2013 Mar 12.
7
Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy.浸润性眼眶的肥大细胞、单核细胞和巨噬细胞产生 PDGF 异构体,从而协调格雷夫斯眼病眼眶成纤维细胞的激活。
J Clin Endocrinol Metab. 2012 Mar;97(3):E400-8. doi: 10.1210/jc.2011-2697. Epub 2012 Jan 11.
8
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.甲磺酸伊马替尼和AMN107抑制眼眶成纤维细胞中的血小板衍生生长因子信号传导:一种治疗格雷夫斯眼病的潜在方法。
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. doi: 10.1167/iovs.08-2443. Epub 2009 Feb 21.
9
A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.一种促甲状腺激素受体抗体 (M22) 和促甲状腺激素可增加 Graves 眼眶前脂肪细胞成纤维细胞中白细胞介素-6 的表达和分泌。
Thyroid. 2010 Jan;20(1):59-65. doi: 10.1089/thy.2009.0278.
10
Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts.碱性成纤维细胞生长因子和血小板衍生生长因子-BB协同刺激眼眶成纤维细胞产生透明质酸和白细胞介素-6。
Mol Cell Endocrinol. 2016 Sep 15;433:94-104. doi: 10.1016/j.mce.2016.05.023. Epub 2016 Jun 3.

引用本文的文献

1
The Use of Biologics for Thyroid Eye Disease.生物制剂在甲状腺眼病中的应用。
BioDrugs. 2025 Jun 6. doi: 10.1007/s40259-025-00726-0.
2
Novel perspectives on the pharmacological treatment of thyroid-associated ophthalmopathy.甲状腺相关性眼病药物治疗的新观点
Front Endocrinol (Lausanne). 2025 Jan 13;15:1469268. doi: 10.3389/fendo.2024.1469268. eCollection 2024.
3
Tapinarof, an Aryl Hydrocarbon Receptor Ligand, Mitigates Fibroblast Activation in Thyroid Eye Disease: Implications for Novel Therapy.他扎罗汀,一种芳烃受体配体,可减轻甲状腺眼病成纤维细胞的活化:对新型治疗方法的启示。
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):40. doi: 10.1167/iovs.65.13.40.
4
TSH enhances neurite outgrowth.促甲状腺激素增强神经突生长。
Front Endocrinol (Lausanne). 2024 Oct 17;15:1463964. doi: 10.3389/fendo.2024.1463964. eCollection 2024.
5
The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves' Ophthalmopathy.纤维生成和细胞外基质蛋白在格雷夫斯眼病发病机制中的作用。
Int J Mol Sci. 2024 Mar 14;25(6):3288. doi: 10.3390/ijms25063288.
6
Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy.成纤维细胞参与甲状腺相关性眼病提示新的治疗方法。
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S9-S18. doi: 10.1097/IOP.0000000000002509. Epub 2023 Dec 4.
7
Roles of four targets in the pathogenesis of graves' orbitopathy.四个靶点在格雷夫斯眼眶病发病机制中的作用。
Heliyon. 2023 Aug 29;9(9):e19250. doi: 10.1016/j.heliyon.2023.e19250. eCollection 2023 Sep.
8
Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves' Orbitopathy.糖皮质激素直接影响眼眶成纤维细胞的透明质酸产生;格雷夫斯眼病中的一个潜在的多效性作用。
Molecules. 2022 Dec 20;28(1):15. doi: 10.3390/molecules28010015.
9
CD11c B Cells Participate in the Pathogenesis of Graves' Disease by Secreting Thyroid Autoantibodies and Cytokines.CD11c+B 细胞通过分泌甲状腺自身抗体和细胞因子参与 Graves 病的发病机制。
Front Immunol. 2022 Mar 21;13:836347. doi: 10.3389/fimmu.2022.836347. eCollection 2022.
10
Progress in the pathogenesis of thyroid-associated ophthalmopathy and new drug development.甲状腺相关性眼病的发病机制进展与新药研发
Taiwan J Ophthalmol. 2020 Jul 17;10(3):174-180. doi: 10.4103/tjo.tjo_18_20. eCollection 2020 Jul-Sep.